Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR52 | Q9Y2T5 | 2/20 | 0.72 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.51 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3341890 | 1.00 | GPR52 (0.72) | GPR52TRPV1ALDH1A1KEAP1ALOX5 | |
| SCHEMBL20661175 | 0.84 | TRPV1 (0.58) | GPR52TRPV1ALDH1A1ALOX5MAPT | |
| SCHEMBL28514524 | 0.84 | TRPV1 (0.58) | GPR52TRPV1ALDH1A1ALOX5MAPT | |
| SCHEMBL7426203 | 0.84 | GPR52 (0.74) | GPR52TRPV1ALDH1A1KEAP1ALOX5 | |
| SCHEMBL7426208 | 0.84 | GPR52 (0.74) | GPR52TRPV1ALDH1A1KEAP1ALOX5 | |
| SCHEMBL6373067 | 0.84 | GPR52 (1.00) | GPR52TRPV1KEAP1ALOX5 | |
| SCHEMBL6373065 | 0.84 | GPR52 (1.00) | GPR52TRPV1KEAP1ALOX5 | |
| SCHEMBL7297626 | 0.82 | GPR52 (0.71) | GPR52TRPV1ALOX5EPHX2SMN1; SMN2 | |
| SCHEMBL7297630 | 0.82 | GPR52 (0.71) | GPR52TRPV1ALOX5EPHX2SMN1; SMN2 | |
| SCHEMBL8733597 | 0.81 | CES1 (0.48) | GPR52ALDH1A1MAPTHDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250041408-A1 | SMALL MOLECULE IMMUNOPOTENTIATOR CONJUGATES OF NFKB ACTIVATORS AS ADJUVANTS WITH ENHANCED EFFICACY AND REDUCED TOXICITY | THE UNIVERSITY OF CHICAGO | 2025-02-06 | — | — | US | disclosed |
| US-11540539-B2 | Reduced sodium food products | GENERAL MILLS, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| US-20200281236-A1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2020-09-10 | — | — | US | disclosed |
| EP-3366677-B1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2020-09-09 | — | — | EP | disclosed |
| EP-3466930-A1 | REDUCED SODIUM FOOD PRODUCT | GENERAL MILLS, INC. (US) | 2019-04-10 | — | — | EP | disclosed |
| US-20190090520-A1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2019-03-28 | — | — | US | disclosed |
| EP-2954037-B1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2018-04-11 | — | — | EP | disclosed |
| EP-2956440-B1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2018-04-11 | — | — | EP | disclosed |
| EP-2953934-B1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2018-04-11 | — | — | EP | disclosed |
| US-9561272-B2 | Compositions and methods for modulating immune responses | THE UNIVERSITY OF QUEENSLAND (AU) | 2017-02-07 | — | — | US | disclosed |
| WO-2014124214-A1 | REDUCED SODIUM FOOD PRODUCTS | GENERAL MILLS, INC. (US) | 2014-08-14 | — | — | WO | disclosed |
| WO-2014124209-A1 | REDUCED SODIUM FOOD PRODUCTS | GENERAL MILLS, INC. (US) | 2014-08-14 | — | — | WO | disclosed |
| WO-2014124198-A1 | REDUCED SODIUM FOOD PRODUCT | GENERAL MILLS, INC. (US) | 2014-08-14 | — | — | WO | disclosed |
| WO-2014124212-A1 | REDUCED SODIUM FOOD PRODUCTS | GENERAL MILLS, INC. (US) | 2014-08-14 | — | — | WO | disclosed |
| WO-2014124222-A1 | REDUCED SODIUM FOOD PRODUCTS | GENERAL MILLS, INC. (US) | 2014-08-14 | — | — | WO | disclosed |
| WO-2014124216-A1 | REDUCED SODIUM FOOD PRODUCT | GENERAL MILLS, INC. (US) | 2014-08-14 | — | — | WO | disclosed |
| WO-2014124220-A1 | REDUCED SODIUM FOOD PRODUCT | GENERAL MILLS, INC. (US) | 2014-08-14 | — | — | WO | disclosed |
| WO-2013138871-A1 | IMMUNOMODULATORY AGENT AND USES THEREFOR | THE UNIVERSITY OF QUEENSLAND (AU) | 2013-09-26 | — | — | WO | disclosed |
| US-20100151000-A1 | COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES | THE UNIVERSITY OF QUEENSLAND (AU) | 2010-06-17 | — | — | US | disclosed |
| US-20060024691-A1 | Novel pathways in the etiology of cancer | BUCK INSTITUTE FOR AGE RESEARCH | 2006-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250041408-A1 | SMALL MOLECULE IMMUNOPOTENTIATOR CONJUGATES OF NFKB ACTIVATORS AS ADJUVANTS WITH ENHANCED EFFICACY AND REDUCED TOXICITY | NFKBIA, NFRKB, NFKB2 | GPR52 393/4885TRPV1 1843/4885ALDH1A1 4393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.